Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jehane Fadlallah

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Mucosal Immunology|August 16, 2019
The antibody/microbiota interface in health and diseaseDelphine Sterlin, Jehane Fadlallah, Emma Slack, et al.
Intensive Care Medicine|August 2, 2018
HHV8-related hemophagocytic syndrome: diagnosis is in the eyeSandrine Valade, Jehane Fadlallah, Jean Edouard Martin, et al.
Science Translational Medicine|March 24, 2017
Comment on "Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination"Christophe Parizot, Hélène Brisson, Jehane Fadlallah, et al.
British Journal of Haematology|April 24, 2025
How we manage immune-mediated thrombotic thrombocytopenic purpura after rituximab failure or intoleranceJulia Weisinger, Jehane Fadlallah, Bérangère Joly, et al.
Gut Microbes|November 20, 2018
Immune/microbial interface perturbation in human IgA deficiencyDelphine Sterlin, Claire Fieschi, Marion Malphettes, et al.
The American Journal of Case Reports|April 7, 2020
Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian PatientsGrégoire Ducoux, Arthur Guerber, Cécile-Audrey Durel, et al.
European Journal of Neurology|April 23, 2025
Primary Neurolymphomatosis: A Literature ReviewSahar Chakroun, Alice Faucher, Antoine Gueguen, et al.
La Revue De Medecine Interne|April 17, 2026
[Bispecific T-cell engagers for the treatment of autoimmune diseases: Current status and therapeutic perspectives]Marion Larue, Benoît Ferment, Vincent Allain, et al.
Blood Advances|June 8, 2023
Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman diseaseCamille Rasmussen, Laurence Gérard, Jehane Fadlallah, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 19, 2022
Campylobacter infection in 4 patients treated with ibrutinibBoris Sorin, Julien Vigneron, Jehane Fadlallah, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Mucosal Immunology|August 16, 2019
The antibody/microbiota interface in health and diseaseDelphine Sterlin, Jehane Fadlallah, Emma Slack, et al.
Intensive Care Medicine|August 2, 2018
HHV8-related hemophagocytic syndrome: diagnosis is in the eyeSandrine Valade, Jehane Fadlallah, Jean Edouard Martin, et al.
Science Translational Medicine|March 24, 2017
Comment on "Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination"Christophe Parizot, Hélène Brisson, Jehane Fadlallah, et al.
British Journal of Haematology|April 24, 2025
How we manage immune-mediated thrombotic thrombocytopenic purpura after rituximab failure or intoleranceJulia Weisinger, Jehane Fadlallah, Bérangère Joly, et al.
Gut Microbes|November 20, 2018
Immune/microbial interface perturbation in human IgA deficiencyDelphine Sterlin, Claire Fieschi, Marion Malphettes, et al.
The American Journal of Case Reports|April 7, 2020
Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian PatientsGrégoire Ducoux, Arthur Guerber, Cécile-Audrey Durel, et al.
European Journal of Neurology|April 23, 2025
Primary Neurolymphomatosis: A Literature ReviewSahar Chakroun, Alice Faucher, Antoine Gueguen, et al.
La Revue De Medecine Interne|April 17, 2026
[Bispecific T-cell engagers for the treatment of autoimmune diseases: Current status and therapeutic perspectives]Marion Larue, Benoît Ferment, Vincent Allain, et al.
Blood Advances|June 8, 2023
Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman diseaseCamille Rasmussen, Laurence Gérard, Jehane Fadlallah, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 19, 2022
Campylobacter infection in 4 patients treated with ibrutinibBoris Sorin, Julien Vigneron, Jehane Fadlallah, et al.
Pageof 6